Y. To

A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma

T. Crocenzi, P. Newell, P. Hansen, 2016, Journal of Immunotherapy for Cancer.

Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment‐Related Adverse Events From the CheckMate 040 Study

M. Tschaika, J. Koh, Yun Shen, 2020, The oncologist.

A Phase II Trial of TGFβ Type I Receptor Inhibitor, Galunisertib, plus Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

W. Urba, G. Vaccaro, M. Crittenden, 2022, International Journal of Radiation Oncology*Biology*Physics.